Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|September 19, 2018
Identification of Compounds Targeting Hepatitis B Virus Core Protein Dimerization through a Split Luciferase Complementation AssayXia-Fei Wei, Chun-Yang Gan, Jing Cui, et al.Iscience|June 6, 2022
Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labelingXia-Fei Wei, Shu-Ying Fan, Yu-Wei Wang, et al.Biosensors & Bioelectronics|April 12, 2022
Protein sensors combining both on-and-off model for antibody homogeneous assayJie Li, Jin-Lan Wang, Wen-Lu Zhang, et al.Nature Medicine|June 20, 2020
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsQuan-Xin Long, Xiao-Jun Tang, Qiu-Lin Shi, et al.Journal of Hepatology|September 28, 2020
Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBxSheng-Tao Cheng, Jie-Li Hu, Ji-Hua Ren, et al.Cell Discovery|March 26, 2021
Immune memory in convalescent patients with asymptomatic or mild COVID-19Quan-Xin Long, Yan-Jun Jia, Xin Wang, et al.Ebiomedicine|November 5, 2019
Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg productionFang Ren, Xiao Yang, Zhong-Wen Hu, et al.Hepatology (Baltimore, Md.)|January 8, 2019
A Functional Variant in Ubiquitin Conjugating Enzyme E2 L3 Contributes to Hepatitis B Virus Infection and Maintains Covalently Closed Circular DNA Stability by Inducing Degradation of Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit 3ALi Zhou, Ji-Hua Ren, Sheng-Tao Cheng, et al.Genes & Diseases|May 5, 2020
The clinical and immunological features of pediatric COVID-19 patients in ChinaJuan Chen, Zhen-Zhen Zhang, Yao-Kai Chen, et al.Clinical Science (London, England : 1979)|June 15, 2021
SIRT7 restricts HBV transcription and replication through catalyzing desuccinylation of histone H3 associated with cccDNA minichromosomeHai-Bo Yu, Sheng-Tao Cheng, Fang Ren, et al.Pageof 5